• Science News
    BrightFocus grantee, Jaehong Suh, Ph.D., of Massachusetts General Hospital and Harvard, is the lead author of this paper and has documented in animal models new disease-causing mutations for Alzheimer’s. These results provide evidence that the ADAM10 gene is a potential therapeutic target for treatment of the late-onset form of this brain disease.
    September 25, 2013
  • Don't miss out.
    Receive research updates, inspiring stories, and expert advice
    Please enter your first name.
    Please enter your last name.
    Keep me informed about: *
    Please select at least one.
    You must select at least one disease category.